{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:41:10Z","timestamp":1767181270037,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1010311","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000}}],"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1DP2AI145058-01"],"award-info":[{"award-number":["1DP2AI145058-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008982","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Antibiotic resistance is an important public health problem. One potential solution is the development of synergistic antibiotic combinations, in which the combination is more effective than the component drugs. However, experimental progress in this direction is severely limited by the number of samples required to exhaustively test for synergy, which grows exponentially with the number of drugs combined. We introduce a new metric for antibiotic synergy, motivated by the popular Fractional Inhibitory Concentration Index and the Highest Single Agent model. We also propose a new experimental design that samples along all appropriately normalized diagonals in concentration space, and prove that this design identifies all synergies among a set of drugs while only sampling a small fraction of the possible combinations. We applied our method to screen two- through eight-way combinations of eight antibiotics at 10 concentrations each, which requires sampling only 2,560 unique combinations of antibiotic concentrations.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1010311","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T13:33:18Z","timestamp":1658151198000},"page":"e1010311","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sample-efficient identification of high-dimensional antibiotic synergy with a normalized diagonal sampling design"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8101-8939","authenticated-orcid":true,"given":"Jennifer","family":"Brennan","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1087-724X","authenticated-orcid":true,"given":"Lalit","family":"Jain","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8933-1057","authenticated-orcid":true,"given":"Sofia","family":"Garman","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-5401","authenticated-orcid":true,"given":"Ann E.","family":"Donnelly","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1457-4019","authenticated-orcid":true,"given":"Erik Scott","family":"Wright","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2054-2985","authenticated-orcid":true,"given":"Kevin","family":"Jamieson","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"issue":"3","key":"pcbi.1010311.ref001","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21st century","volume":"17","author":"M Tyers","year":"2019","journal-title":"Nature Reviews Microbiology"},{"issue":"1","key":"pcbi.1010311.ref002","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1476-5381.1968.tb00475.x","article-title":"Trimethoprim, a sulphonamide potentiator","volume":"33","author":"S Bushby","year":"1968","journal-title":"British journal of pharmacology and chemotherapy"},{"issue":"9","key":"pcbi.1010311.ref003","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/AAC.03389-14","article-title":"Synergy of streptogramin antibiotics occurs independently of their effects on translation","volume":"58","author":"J Noeske","year":"2014","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"7","key":"pcbi.1010311.ref004","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-4362.1994.tb02872.x","article-title":"In vitro interactions of neomycin sulfate, bacitracin, and polymyxin B sulfate","volume":"33","author":"JH Booth","year":"1994","journal-title":"International journal of dermatology"},{"issue":"1","key":"pcbi.1010311.ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41540-018-0069-9","article-title":"Prevalence and patterns of higher-order drug interactions in Escherichia coli","volume":"4","author":"E Tekin","year":"2018","journal-title":"NPJ systems biology and applications"},{"issue":"125","key":"pcbi.1010311.ref006","doi-asserted-by":"crossref","first-page":"20160800","DOI":"10.1098\/rsif.2016.0800","article-title":"Uncovering emergent interactions in three-way combinations of stressors","volume":"13","author":"C Beppler","year":"2016","journal-title":"Journal of the Royal Society Interface"},{"issue":"1","key":"pcbi.1010311.ref007","doi-asserted-by":"crossref","first-page":"e1006774","DOI":"10.1371\/journal.pcbi.1006774","article-title":"Prediction of ultra-high-order antibiotic combinations based on pairwise interactions","volume":"15","author":"I Katzir","year":"2019","journal-title":"PLoS computational biology"},{"issue":"30","key":"pcbi.1010311.ref008","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1073\/pnas.1201281109","article-title":"Mechanism-independent method for predicting response to multidrug combinations in bacteria","volume":"109","author":"K Wood","year":"2012","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"pcbi.1010311.ref009","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/dkaa543","article-title":"Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening","volume":"76","author":"KN Kragh","year":"2021","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"pcbi.1010311.ref010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"CI Bliss","year":"1939","journal-title":"Annals of applied biology"},{"issue":"2","key":"pcbi.1010311.ref011","first-page":"93","article-title":"What is synergy?","volume":"41","author":"MC Berenbaum","year":"1989","journal-title":"Pharmacological reviews"},{"issue":"6","key":"pcbi.1010311.ref012","first-page":"289","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"S Loewe","year":"1953","journal-title":"Arzneimittel Forschung"},{"issue":"3","key":"pcbi.1010311.ref013","doi-asserted-by":"crossref","first-page":"e00149","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"J Foucquier","year":"2015","journal-title":"Pharmacology research & perspectives"},{"key":"pcbi.1010311.ref014","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"TC Chou","year":"1983","journal-title":"Trends in Pharmacological Sciences"},{"issue":"5","key":"pcbi.1010311.ref015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/11.5.427","article-title":"The fractional inhibitory concentration (FIC) index as a measure of synergy","volume":"11","author":"M Hall","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"119","key":"pcbi.1010311.ref016","doi-asserted-by":"crossref","first-page":"20160332","DOI":"10.1098\/rsif.2016.0332","article-title":"Enhanced identification of synergistic and antagonistic emergent interactions among three or more drugs","volume":"13","author":"E Tekin","year":"2016","journal-title":"Journal of The Royal Society Interface"},{"issue":"1","key":"pcbi.1010311.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-017-1017-3","article-title":"When more is less: emergent suppressive interactions in three-drug combinations","volume":"17","author":"C Beppler","year":"2017","journal-title":"BMC microbiology"},{"issue":"10","key":"pcbi.1010311.ref018","doi-asserted-by":"crossref","first-page":"e1701881","DOI":"10.1126\/sciadv.1701881","article-title":"Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis","volume":"3","author":"M Cokol","year":"2017","journal-title":"Science advances"},{"issue":"12","key":"pcbi.1010311.ref019","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41564-018-0252-1","article-title":"Additivity of inhibitory effects in multidrug combinations","volume":"3","author":"D Russ","year":"2018","journal-title":"Nature microbiology"},{"issue":"37","key":"pcbi.1010311.ref020","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1073\/pnas.1606301113","article-title":"Prediction of multidimensional drug dose responses based on measurements of drug pairs","volume":"113","author":"A Zimmer","year":"2016","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"37","key":"pcbi.1010311.ref021","doi-asserted-by":"crossref","first-page":"10231","DOI":"10.1073\/pnas.1612365113","article-title":"Pairwise interactions and the battle against combinatorics in multidrug therapies","volume":"113","author":"KB Wood","year":"2016","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7","key":"pcbi.1010311.ref022","doi-asserted-by":"crossref","first-page":"e0235929","DOI":"10.1371\/journal.pone.0235929","article-title":"Guided screen for synergistic three-drug combinations","volume":"15","author":"M Cokol-Cakmak","year":"2020","journal-title":"PloS one"},{"issue":"1","key":"pcbi.1010311.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48410-y","article-title":"Design of high-order antibiotic combinations against M. tuberculosis by ranking and exclusion","volume":"9","author":"K Yilancioglu","year":"2019","journal-title":"Scientific reports"},{"issue":"1","key":"pcbi.1010311.ref024","doi-asserted-by":"crossref","first-page":"e1008529","DOI":"10.1371\/journal.pcbi.1008529","article-title":"Minimal biophysical model of combined antibiotic action","volume":"17","author":"B Kav\u010di\u010d","year":"2021","journal-title":"PLoS Computational Biology"},{"issue":"5","key":"pcbi.1010311.ref025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cels.2019.10.004","article-title":"Emergent gene expression responses to drug combinations predict higher-order drug interactions","volume":"9","author":"M Luka\u010di\u0161in","year":"2019","journal-title":"Cell Systems"},{"issue":"12","key":"pcbi.1010311.ref026","doi-asserted-by":"crossref","first-page":"e1006677","DOI":"10.1371\/journal.pcbi.1006677","article-title":"Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment","volume":"14","author":"M Cokol","year":"2018","journal-title":"PLoS computational biology"},{"issue":"1","key":"pcbi.1010311.ref027","first-page":"1","article-title":"Synergy, additivism and antagonism in immunosuppression. A critical review","volume":"28","author":"MC Berenbaum","year":"1977","journal-title":"Clinical and experimental immunology"},{"key":"pcbi.1010311.ref028","unstructured":"The European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0; 2021. Available from: http:\/\/www.eucast.org."},{"issue":"1","key":"pcbi.1010311.ref029","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.88.1.99","article-title":"The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms","volume":"88","author":"H Eagle","year":"1948","journal-title":"The Journal of experimental medicine"},{"issue":"4","key":"pcbi.1010311.ref030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tim.2018.10.007","article-title":"The eagle effect and antibiotic-induced persistence: two sides of the same coin?","volume":"27","author":"A Prasetyoputri","year":"2019","journal-title":"Trends in microbiology"},{"issue":"5","key":"pcbi.1010311.ref031","doi-asserted-by":"crossref","first-page":"872","DOI":"10.15252\/msb.20156777","article-title":"Chemogenomics and orthology-based design of antibiotic combination therapies","volume":"12","author":"S Chandrasekaran","year":"2016","journal-title":"Molecular systems biology"},{"issue":"5","key":"pcbi.1010311.ref032","doi-asserted-by":"crossref","first-page":"e96580","DOI":"10.1371\/journal.pone.0096580","article-title":"Quantifying synergy: a systematic review of mixture toxicity studies within environmental toxicology","volume":"9","author":"N Cedergreen","year":"2014","journal-title":"PloS one"},{"issue":"2","key":"pcbi.1010311.ref033","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1213\/ane.0b013e31817b859e","article-title":"Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility","volume":"107","author":"JF Hendrickx","year":"2008","journal-title":"Anesthesia & Analgesia"},{"issue":"7","key":"pcbi.1010311.ref034","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nrc1887","article-title":"Drug interactions in cancer therapy","volume":"6","author":"CD Scripture","year":"2006","journal-title":"Nature Reviews Cancer"},{"issue":"6","key":"pcbi.1010311.ref035","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"J O\u2019Neil","year":"2016","journal-title":"Molecular cancer therapeutics"},{"issue":"9","key":"pcbi.1010311.ref036","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41375-018-0225-7","article-title":"Dual inhibition of JAK1\/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia","volume":"32","author":"SE Kurtz","year":"2018","journal-title":"Leukemia"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1010311","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T14:43:53Z","timestamp":1659019433000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010311"}},"subtitle":[],"editor":[{"given":"Peter M","family":"Kasson","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1010311","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]}}}